Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iqvia Holdings Inc
(NY:
IQV
)
248.97
+0.37 (+0.15%)
Streaming Delayed Price
Updated: 11:45 AM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iqvia Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Analyst Ratings for IQVIA Hldgs
January 13, 2023
Via
Benzinga
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
January 11, 2023
These healthcare companies' revenue and earnings have grown, and they expect more growth.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
December 06, 2022
Via
Benzinga
Expert Ratings for IQVIA Hldgs
December 06, 2022
Via
Benzinga
Where IQVIA Hldgs Stands With Analysts
November 17, 2022
Via
Benzinga
Analyst Ratings for IQVIA Hldgs
November 17, 2022
Via
Benzinga
8 Analysts Have This to Say About IQVIA Hldgs
October 27, 2022
IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Veracyte Stock Showing Market Leadership; Earns 93 RS Rating
December 01, 2022
Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
Upgrades
Via
Benzinga
7 Analysts Have This to Say About IQVIA Hldgs
October 06, 2022
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:
Via
Benzinga
Expert Ratings for IQVIA Hldgs
September 12, 2022
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:
Via
Benzinga
6 Analysts Have This to Say About IQVIA Hldgs
September 12, 2022
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:
Via
Benzinga
Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings
November 17, 2022
Piper Sandler boosted the price target on Target Corporation (NYSE: TGT) from $190 to $200. Target shares fell 13.1% to close at $155.47 on Wednesday.
Via
Benzinga
IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel
November 10, 2022
From
IQVIA
Via
Business Wire
General Electric To Rally Around 14%? Here Are 5 Other Price Target Changes For Thursday
October 27, 2022
Morgan Stanley raised General Electric Company (NYSE: GE) price target from $85 to $88. Morgan Stanley analyst Joshua Pokrzywinski maintained the stock with an Overweight rating. GE shares rose 2.2%...
Via
Benzinga
IQVIA: Q3 Earnings Insights
October 26, 2022
IQVIA Hldgs (NYSE:IQV) reported its Q3 earnings results on Wednesday, October 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IQVIA Hldgs beat estimated...
Via
Benzinga
What 5 Analyst Ratings Have To Say About IQVIA Hldgs
August 25, 2022
Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings:
Via
Benzinga
5 Analysts Have This to Say About IQVIA Hldgs
August 25, 2022
Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings:
Via
Benzinga
IQVIA Reports Third-Quarter 2022 Results
October 26, 2022
From
IQVIA Holdings Inc.
Via
Business Wire
Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies
October 25, 2022
Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.
Via
Investor's Business Daily
Biosimilars Are Revolutionizing Healthcare: Is This Industry Leader a Buy?
October 25, 2022
Biosimilars are bringing down prescription drug costs without sacrificing quality.
Via
The Motley Fool
IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022
October 24, 2022
From
IQVIA Holdings Inc.
Via
Business Wire
Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso
October 06, 2022
From
IQVIA
Via
Business Wire
Tesla To $370? Plus HC Wainwright Slashes PT On This Stock By 67%
October 06, 2022
HC Wainwright & Co. cut KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) price target from $48 to $16. KalVista Pharmaceuticals shares fell 1.8% to $5.06 in pre-market trading.
Via
Benzinga
IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022
October 03, 2022
From
IQVIA Holdings Inc.
Via
Business Wire
IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation
September 28, 2022
From
IQVIA
Via
Business Wire
New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials
September 07, 2022
From
IQVIA
Via
Business Wire
IQVIA CEO Ari Bousbib to Speak at Baird Global Healthcare Conference on September 14, 2022
September 02, 2022
From
IQVIA
Via
Business Wire
IQVIA CFO Ron Bruehlman to Speak at Morgan Stanley Annual Global Healthcare Conference on September 13, 2022
September 01, 2022
From
IQVIA Holdings Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.